Biohaven Ltd. (BHVN) stock
BHVNNYSEPharmaceutical PreparationsFiscal year ends December 31
$13.24−0.56 (-4.06%)
Close on Nov 17, 2026Market cap $2.00BP/E –Yield –
Biohaven enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Biohaven's enterprise value was $2.29B on Nov 11, 2026, against $1.07B a year earlier. Over the last 5 years it ranged from -$50.67M to $5.52B, with a median of $2.13B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $2.29B | +90.1% |
| 2025 | Dec 31, 2025 | $1.20B | -62.0% |
| 2024 | Dec 31, 2024 | $3.17B | +17.9% |
| 2023 | Dec 29, 2023 | $2.69B | – |
| 2022 | Dec 30, 2022 | -$50.67M | -100.9% |
| 2021 | Dec 31, 2021 | $5.34B | – |
See a number that looks wrong?